Nirmatrelvir + Ritonavir Paxzen Tablet
Coronavirus disease (COVID-19)
| Product | Nirmatrelvir + Ritonavir Paxzen Tablet |
|---|---|
| Used for | Coronavirus disease (COVID-19) |
| Dosage form | Tablet |
| Pack | Standard manufacturer pack |
| Manufacturer | Zenara Pharma |
| Composition | Nirmatrelvir (150mg) + Ritonavir (100mg) |
| Strength | Nirmatrelvir (150mg) + Ritonavir (100mg) |
| Pack size | 30 Tablet |
| Packaging | Strips |
| Shelf life | 1 Years |
| Storage | Store below 30°C, away from light and moisture. |
| Country of origin | India |
No payment is taken on this site. We reply with price, batch, expiry and shipping cost. Ask about this product on WhatsApp
Nirmatrelvir + Ritonavir Paxzen Tablet is a tablet in our Cardiac & Blood Pressure range, used for coronavirus disease (covid-19).
Paxzen Tablet is intended to treat mild-to-moderate coronavirus disease(COVID-19) in adults and children aged 12 years and older weighing at least 40 kg with a positive COVID-19 test and at risk of progression to severe disease. It reduces the ability of the coronavirus to multiply in the body. Paxzen Tablet works by stopping the virus from making copies of itself from being effective, it needs to be started within five days of developing COVID symptoms. It is meant for oral intake regardless of the meals. Stick to the dose and duration as prescribed by the doctor. Do not withdraw it abruptly, even if the symptoms improve within the initial few days of the ingestion and report if it worsens after five days. Complete the medicine course as prescribed. Never self-medicate at home based on symptoms without a confirmatory covid-19 test and the doctor’s prescription. Some transient side-effects of Paxzen Tablet include dysgeusia (altered taste), diarrhea, hypertension, myalgia (muscle pain) and vomiting. Consult the doctor right away in case of worrisome episodes.
Antihypertensives, heart-failure therapy, statins and anticoagulants.
This is a prescription medicine and must be used under the supervision of a registered medical practitioner.
